Biomaterial Strategies for Immunomodulation.
暂无分享,去创建一个
Li Tang | Nathan A Hotaling | Darrell J Irvine | D. Irvine | L. Tang | J. Babensee | Julia E Babensee
[1] Youngjin Choi,et al. Injectable, spontaneously assembling inorganic scaffolds modulate immune cells in vivo and increase vaccine efficacy , 2014, Nature Biotechnology.
[2] J. Babensee,et al. Phenotype and polarization of autologous T cells by biomaterial-treated dendritic cells. , 2015, Journal of biomedical materials research. Part A.
[3] Nathan A Hotaling,et al. Presentation Modality of Glycoconjugates Modulates Dendritic Cell Phenotype. , 2014, Biomaterials science.
[4] Nathan A Hotaling,et al. Molecular factors in dendritic cell responses to adsorbed glycoconjugates. , 2014, Biomaterials.
[5] R. Compans,et al. Nanoclusters self-assembled from conformation-stabilized influenza M2e as broadly cross-protective influenza vaccines. , 2014, Nanomedicine : nanotechnology, biology, and medicine.
[6] Krishnendu Roy,et al. Generation of Functional, Antigen‐Specific CD8+ Human T Cells from Cord Blood Stem Cells Using Exogenous Notch and Tetramer‐TCR Signaling , 2014, Stem cells.
[7] Duccio Cavalieri,et al. Carbon nanotube scaffolds instruct human dendritic cells: modulating immune responses by contacts at the nanoscale. , 2013, Nano letters.
[8] Joel H Collier,et al. The use of self-adjuvanting nanofiber vaccines to elicit high-affinity B cell responses to peptide antigens without inflammation. , 2013, Biomaterials.
[9] A. Thomson,et al. All‐trans retinoic acid and rapamycin synergize with transforming growth factor‐β1 to induce regulatory T cells but confer different migratory capacities , 2013, Journal of leukocyte biology.
[10] D. Irvine,et al. Generation of Effector Memory T Cell–Based Mucosal and Systemic Immunity with Pulmonary Nanoparticle Vaccination , 2013, Science Translational Medicine.
[11] J. Collier,et al. A Self‐Adjuvanting Supramolecular Vaccine Carrying a Folded Protein Antigen , 2013, Advanced healthcare materials.
[12] Molly S Bray,et al. Integrative genomic analysis of the human immune response to influenza vaccination , 2013, eLife.
[13] Lucia Gemma Delogu,et al. Functionalized carbon nanotubes as immunomodulator systems. , 2013, Biomaterials.
[14] Darrell J Irvine,et al. In vivo targeting of adoptively transferred T-cells with antibody- and cytokine-conjugated liposomes. , 2013, Journal of controlled release : official journal of the Controlled Release Society.
[15] Yaping Li,et al. Physicochemical characteristics of nanoparticles affect circulation, biodistribution, cellular internalization, and trafficking. , 2013, Small.
[16] D. Wraith,et al. Regulation of Adaptive Immunity; The Role of Interleukin-10 , 2013, Front. Immunol..
[17] K. Nazmi,et al. Multivalent glycopeptide dendrimers for the targeted delivery of antigens to dendritic cells. , 2013, Molecular immunology.
[18] T. Fahmy,et al. Nanogel-based delivery of mycophenolic acid ameliorates systemic lupus erythematosus in mice. , 2013, The Journal of clinical investigation.
[19] Sebastian J Maerkl,et al. A high-throughput nanoimmunoassay chip applied to large-scale vaccine adjuvant screening. , 2013, Integrative biology : quantitative biosciences from nano to macro.
[20] Tarek R. Fadel,et al. Adsorption of multimeric T cell antigens on carbon nanotubes: effect on protein structure and antigen-specific T cell stimulation. , 2013, Small.
[21] R. Hayward,et al. Tuning Innate Immune Activation by Surface Texturing of Polymer Microparticles: The Role of Shape in Inflammasome Activation , 2013, The Journal of Immunology.
[22] K. Ravichandran,et al. Clearing the dead: apoptotic cell sensing, recognition, engulfment, and digestion. , 2013, Cold Spring Harbor perspectives in biology.
[23] Aaron J. Martin,et al. Microparticles bearing encephalitogenic peptides induce T-cell tolerance and ameliorate experimental autoimmune encephalomyelitis , 2012, Nature Biotechnology.
[24] Mark Coles,et al. Application of tissue engineering to the immune system: development of artificial lymph nodes , 2012, Front. Immun..
[25] D. Greiner,et al. Humanized mice for immune system investigation: progress, promise and challenges , 2012, Nature Reviews Immunology.
[26] Aliasger K. Salem,et al. Biodegradable Particles as Vaccine Delivery Systems: Size Matters , 2012, The AAPS Journal.
[27] Richard A Flavell,et al. Combination delivery of TGF-β inhibitor and IL-2 by nanoscale liposomal polymeric gels enhances tumour immunotherapy. , 2012, Nature materials.
[28] J. Babensee,et al. Differential functional effects of biomaterials on dendritic cell maturation. , 2012, Acta biomaterialia.
[29] F. Chueh,et al. Engagement of T-cell antigen receptor and CD4/CD8 co-receptors induces prolonged STAT activation through autocrine/paracrine stimulation in human primary T cells. , 2012, Biochemical and biophysical research communications.
[30] Satish Mishra,et al. Self-assembled peptide nanofibers raising durable antibody responses against a malaria epitope. , 2012, Biomaterials.
[31] D. Irvine,et al. Synapse-directed delivery of immunomodulators using T-cell-conjugated nanoparticles. , 2012, Biomaterials.
[32] D. Jackson,et al. Control of size dispersity of chitosan biopolymer microparticles and nanoparticles to influence vaccine trafficking and cell uptake. , 2012, Journal of biomedical materials research. Part A.
[33] Francisco J. Quintana,et al. Nanoparticle-mediated codelivery of myelin antigen and a tolerogenic small molecule suppresses experimental autoimmune encephalomyelitis , 2012, Proceedings of the National Academy of Sciences.
[34] David C. Smith,et al. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. , 2012, The New England journal of medicine.
[35] Benjamin C. Tang,et al. Mucus-Penetrating Nanoparticles for Vaginal Drug Delivery Protect Against Herpes Simplex Virus , 2012, Science Translational Medicine.
[36] Koichiro Uto,et al. Substrate stiffness modulates gene expression and phenotype in neonatal cardiomyocytes in vitro. , 2012, Tissue engineering. Part A.
[37] R. Locksley,et al. Spatiotemporally separated antigen uptake by alveolar dendritic cells and airway presentation to T cells in the lung , 2012, The Journal of experimental medicine.
[38] M. Nouri-Shirazi,et al. Macrophage chitin binding proteins in phagocytosis and M1 activation in response to chitin microparticles (172.27) , 2012, The Journal of Immunology.
[39] K. Anseth,et al. Strategies to reduce dendritic cell activation through functional biomaterial design. , 2012, Biomaterials.
[40] James J Moon,et al. Engineering Nano‐ and Microparticles to Tune Immunity , 2012, Advanced materials.
[41] M. Bachmann,et al. Innate Immunity Mediates Follicular Transport of Particulate but Not Soluble Protein Antigen , 2012, The Journal of Immunology.
[42] A. Thomson,et al. Controlled release formulations of IL-2, TGF-β1 and rapamycin for the induction of regulatory T cells. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[43] K. Leong,et al. Synthetic mast-cell granules as adjuvants to promote and polarize immunity in lymph nodes. , 2012, Nature materials.
[44] J. Babensee,et al. Predicting biomaterial property-dendritic cell phenotype relationships from the multivariate analysis of responses to polymethacrylates. , 2012, Biomaterials.
[45] Joel H Collier,et al. Modulating adaptive immune responses to peptide self-assemblies. , 2012, ACS nano.
[46] D. Irvine,et al. Enhancing humoral responses to a malaria antigen with nanoparticle vaccines that expand Tfh cells and promote germinal center induction , 2012, Proceedings of the National Academy of Sciences.
[47] T. Eberlein. Durable Complete Responses in Heavily Pretreated Patients with metastatic Melanoma Using T-Cell Transfer Immunotherapy , 2012 .
[48] George Coukos,et al. Cancer immunotherapy comes of age , 2011, Nature.
[49] Ling Peng,et al. Systemic administration of combinatorial dsiRNAs via nanoparticles efficiently suppresses HIV-1 infection in humanized mice. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.
[50] K. Landfester,et al. Criteria impacting the cellular uptake of nanoparticles: a study emphasizing polymer type and surfactant effects. , 2011, Acta biomaterialia.
[51] S. Mitragotri,et al. Adaptive micro and nanoparticles: temporal control over carrier properties to facilitate drug delivery. , 2011, Advanced drug delivery reviews.
[52] Ashutosh Kumar Singh,et al. An injectable synthetic immune-priming center mediates efficient T-cell class switching and T-helper 1 response against B cell lymphoma. , 2011, Journal of controlled release : official journal of the Controlled Release Society.
[53] A. Traboulsee,et al. A phase III study evaluating the efficacy and safety of MBP8298 in secondary progressive MS , 2011, Neurology.
[54] R. Gold,et al. Liposomal Encapsulation of Glucocorticoids Alters Their Mode of Action in the Treatment of Experimental Autoimmune Encephalomyelitis , 2011, The Journal of Immunology.
[55] J. Hubbell,et al. Nanoparticle conjugation of antigen enhances cytotoxic T-cell responses in pulmonary vaccination , 2011, Proceedings of the National Academy of Sciences.
[56] J. Hubbell,et al. Nanoparticle conjugation and pulmonary delivery enhance the protective efficacy of Ag85B and CpG against tuberculosis. , 2011, Vaccine.
[57] V. Rotello,et al. Modulating Pharmacokinetics, Tumor Uptake and Biodistribution by Engineered Nanoparticles , 2011, PloS one.
[58] D. Irvine,et al. In situ engineering of the lymph node microenvironment via intranodal injection of adjuvant-releasing polymer particles , 2011, Proceedings of the National Academy of Sciences.
[59] Thommey P. Thomas,et al. Folate-targeted nanoparticles show efficacy in the treatment of inflammatory arthritis. , 2011, Arthritis and rheumatism.
[60] Jun Jiao,et al. Alpha-alumina nanoparticles induce efficient autophagy-dependent cross-presentation and potent antitumour response , 2011, Nature nanotechnology.
[61] Tarek R. Fadel,et al. An Artificial Antigen-presenting Cell with Paracrine Delivery of IL-2 Impacts the Magnitude and Direction of the T Cell Response* , 2011, The Journal of Biological Chemistry.
[62] Eva K. Lee,et al. Systems Biology of Seasonal Influenza Vaccination in Humans , 2011, Nature Immunology.
[63] T. Fahmy,et al. Pathogen-associated molecular patterns on biomaterials: a paradigm for engineering new vaccines. , 2011, Trends in biotechnology.
[64] S. Akira,et al. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. , 2011, Immunity.
[65] Kit S Lam,et al. The effect of surface charge on in vivo biodistribution of PEG-oligocholic acid based micellar nanoparticles. , 2011, Biomaterials.
[66] Ping Zhang,et al. Alum interaction with dendritic cell membrane lipids is essential for its adjuvanticity , 2011, Nature Medicine.
[67] Jangwook P. Jung,et al. Multifactorial optimization of endothelial cell growth using modular synthetic extracellular matrices. , 2011, Integrative biology : quantitative biosciences from nano to macro.
[68] J. Babensee,et al. Dendritic cell responses to surface properties of clinical titanium surfaces. , 2011, Acta biomaterialia.
[69] Jason Park,et al. Modulation of CD4+ T lymphocyte lineage outcomes with targeted, nanoparticle-mediated cytokine delivery. , 2011, Molecular pharmaceutics.
[70] J. Babensee,et al. The role of integrins in the recognition and response of dendritic cells to biomaterials. , 2011, Biomaterials.
[71] Wah Chiu,et al. Interbilayer-Crosslinked Multilamellar Vesicles as Synthetic Vaccines for Potent Humoral and Cellular Immune Responses , 2011, Nature materials.
[72] S. Reed,et al. Use of defined TLR ligands as adjuvants within human vaccines , 2011, Immunological reviews.
[73] L. Kaminskas,et al. Nanosized Drug Delivery Vectors and the Reticuloendothelial System , 2011 .
[74] D. Mooney,et al. Immunologically active biomaterials for cancer therapy. , 2011, Current topics in microbiology and immunology.
[75] Robert Langer,et al. Polymer surface functionalities that control human embryoid body cell adhesion revealed by high throughput surface characterization of combinatorial material microarrays. , 2010, Biomaterials.
[76] J. Tschopp,et al. Nanoparticles activate the NLR pyrin domain containing 3 (Nlrp3) inflammasome and cause pulmonary inflammation through release of IL-1α and IL-1β , 2010, Proceedings of the National Academy of Sciences.
[77] W. Saltzman,et al. Vaccine delivery by polymeric vehicles in the mouse reproductive tract induces sustained local and systemic immunity. , 2010, Molecular pharmaceutics.
[78] An Lebacq,et al. Gene Expression Study of Monocytes/Macrophages during Early Foreign Body Reaction and Identification of Potential Precursors of Myofibroblasts , 2010, PloS one.
[79] J. Babensee,et al. Biomaterial adjuvant effect is attenuated by anti-inflammatory drug delivery or material selection. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[80] E. Fikrig,et al. TLR9-Targeted Biodegradable Nanoparticles as Immunization Vectors Protect against West Nile Encephalitis , 2010, The Journal of Immunology.
[81] D. Schadendorf,et al. Improved survival with ipilimumab in patients with metastatic melanoma. , 2010, The New England journal of medicine.
[82] C. Coban,et al. The role of multiple toll-like receptor signalling cascades on interactions between biomedical polymers and dendritic cells. , 2010, Biomaterials.
[83] Bali Pulendran,et al. Programming dendritic cells to induce TH2 and tolerogenic responses , 2010, Nature Immunology.
[84] Joseph M. DeSimone,et al. Strategies in the design of nanoparticles for therapeutic applications , 2010, Nature Reviews Drug Discovery.
[85] J. Babensee,et al. Validation of a high-throughput methodology to assess the effects of biomaterials on dendritic cell phenotype. , 2010, Acta biomaterialia.
[86] Uwe Marx,et al. Immunological substance testing on human lymphatic micro-organoids in vitro. , 2010, Journal of biotechnology.
[87] Samir Mitragotri,et al. Factors that control the circulation time of nanoparticles in blood: challenges, solutions and future prospects. , 2010, Current pharmaceutical design.
[88] Soong Ho Um,et al. Therapeutic cell engineering using surface-conjugated synthetic nanoparticles , 2010, Nature Medicine.
[89] Cui Tang,et al. Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles. , 2010, Biomaterials.
[90] Pau Serra,et al. Reversal of autoimmunity by boosting memory-like autoregulatory T cells. , 2010, Immunity.
[91] S. Yoo,et al. Highly ordered hexagonal arrays of hybridized micelles from bimodal self-assemblies of diblock copolymer micelles. , 2010, Macromolecular rapid communications.
[92] E. Topp,et al. Immune response to controlled release of immunomodulating peptides in a murine experimental autoimmune encephalomyelitis (EAE) model. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[93] S. Mitragotri,et al. Endocytosis and Intracellular Distribution of PLGA Particles in Endothelial Cells: Effect of Particle Geometry. , 2010, Macromolecular rapid communications.
[94] Takeshi Watanabe,et al. Artificial engineering of secondary lymphoid organs. , 2010, Advances in immunology.
[95] D. Mueller. Mechanisms maintaining peripheral tolerance , 2010, Nature Immunology.
[96] Jangwook P. Jung,et al. A self-assembling peptide acting as an immune adjuvant , 2009, Proceedings of the National Academy of Sciences.
[97] Samuel K. Lai,et al. Nanoparticles reveal that human cervicovaginal mucus is riddled with pores larger than viruses , 2009, Proceedings of the National Academy of Sciences.
[98] D. Irvine,et al. Engulfing tumors with synthetic extracellular matrices for cancer immunotherapy. , 2009, Biomaterials.
[99] David J Mooney,et al. In Situ Regulation of DC Subsets and T Cells Mediates Tumor Regression in Mice , 2009, Science Translational Medicine.
[100] T. Fahmy,et al. Biomimetic approaches to modulating the T cell immune response with nano- and micro- particles , 2009, 2009 Annual International Conference of the IEEE Engineering in Medicine and Biology Society.
[101] Ashutosh Kumar Singh,et al. In-situ crosslinking hydrogels for combinatorial delivery of chemokines and siRNA-DNA carrying microparticles to dendritic cells. , 2009, Biomaterials.
[102] Melody A. Swartz,et al. Fluid Flow Regulates Stromal Cell Organization and CCL21 Expression in a Tissue-Engineered Lymph Node Microenvironment1 , 2009, The Journal of Immunology.
[103] S. Riddell,et al. Safety and immunologic effects of IL-15 administration in nonhuman primates. , 2009, Blood.
[104] R. Parkhill,et al. An Immunologic Model for Rapid Vaccine Assessment — A Clinical Trial in a Test Tube , 2009, Alternatives to laboratory animals : ATLA.
[105] Yuan Yuan,et al. Long-circulation of hemoglobin-loaded polymeric nanoparticles as oxygen carriers with modulated surface charges. , 2009, International journal of pharmaceutics.
[106] T. Xia,et al. Understanding biophysicochemical interactions at the nano-bio interface. , 2009, Nature materials.
[107] Richard A Flavell,et al. Inflammasome-activating nanoparticles as modular systems for optimizing vaccine efficacy. , 2009, Vaccine.
[108] Yuan Yuan,et al. Long-circulating polymeric nanoparticles bearing a combinatorial coating of PEG and water-soluble chitosan. , 2009, Biomaterials.
[109] U. Aebi,et al. Peptide nanoparticles serve as a powerful platform for the immunogenic display of poorly antigenic actin determinants. , 2009, Journal of molecular biology.
[110] Kenny K. Tran,et al. The role of phagosomal pH on the size-dependent efficiency of cross-presentation by dendritic cells. , 2009, Biomaterials.
[111] J. Collins,et al. Anionic PAMAM dendrimers as drug delivery vehicles for transition metal-based anticancer drugs. , 2009, Journal of inorganic biochemistry.
[112] J. Hanes,et al. Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues. , 2009, Advanced drug delivery reviews.
[113] H. Hammad,et al. Mechanism of action of clinically approved adjuvants. , 2009, Current opinion in immunology.
[114] David J. Mooney,et al. Infection-Mimicking Materials to Program Dendritic Cells In Situ , 2008, Nature materials.
[115] D. Irvine,et al. Modular injectable matrices based on alginate solution/microsphere mixtures that gel in situ and co-deliver immunomodulatory factors. , 2008, Acta biomaterialia.
[116] Benjamin G Keselowsky,et al. Adhesive substrate-modulation of adaptive immune responses. , 2008, Biomaterials.
[117] Ashutosh Kumar Singh,et al. Efficient modulation of T-cell response by dual-mode, single-carrier delivery of cytokine-targeted siRNA and DNA vaccine to antigen-presenting cells. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.
[118] Aaron J. Martin,et al. ECDI-fixed allogeneic splenocytes induce donor-specific tolerance for long-term survival of islet transplants via two distinct mechanisms , 2008, Proceedings of the National Academy of Sciences.
[119] D. Irvine,et al. Injectable dendritic cell-carrying alginate gels for immunization and immunotherapy. , 2008, Biomaterials.
[120] Mark E. Davis,et al. Nanoparticle therapeutics: an emerging treatment modality for cancer , 2008, Nature Reviews Drug Discovery.
[121] Ke-Xin Zhang,et al. Shape effects of nanoparticles conjugated with cell-penetrating peptides (HIV Tat PTD) on CHO cell uptake. , 2008, Bioconjugate chemistry.
[122] K. Rock,et al. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization , 2008, Nature Immunology.
[123] Samir Mitragotri,et al. Control of endothelial targeting and intracellular delivery of therapeutic enzymes by modulating the size and shape of ICAM-1-targeted carriers. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.
[124] Eric Pridgen,et al. Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles , 2008, Molecular pharmaceutics.
[125] Jianhong Cao,et al. Treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1. , 2008, The New England journal of medicine.
[126] Tarek R. Fadel,et al. Enhanced cellular activation with single walled carbon nanotube bundles presenting antibody stimuli. , 2008, Nano letters.
[127] D. Irvine,et al. Inverse opal hydrogel-collagen composite scaffolds as a supportive microenvironment for immune cell migration. , 2008, Journal of biomedical materials research. Part A.
[128] Katrin Schwarz,et al. Nanoparticles target distinct dendritic cell populations according to their size , 2008, European journal of immunology.
[129] J. Babensee. Interaction of dendritic cells with biomaterials. , 2008, Seminars in immunology.
[130] D. Irvine,et al. Lymphoid tissue engineering: invoking lymphoid tissue neogenesis in immunotherapy and models of immunity. , 2008, Seminars in immunology.
[131] Samir Mitragotri,et al. Role of Particle Size in Phagocytosis of Polymeric Microspheres , 2008, Pharmaceutical Research.
[132] M. Sixt,et al. The microanatomy of T‐cell responses , 2008, Immunological reviews.
[133] K. Sheng,et al. Delivery of antigen using a novel mannosylated dendrimer potentiates immunogenicity in vitro and in vivo , 2008, European journal of immunology.
[134] T. Koga,et al. Self-Assembled Peptide Nanofibers , 2008 .
[135] S. Mackinnon,et al. Adoptive cellular therapy for cytomegalovirus infection following allogeneic stem cell transplantation using virus-specific T cells. , 2008, Blood cells, molecules & diseases.
[136] Mauro Ferrari,et al. Intravascular Delivery of Particulate Systems: Does Geometry Really Matter? , 2008, Pharmaceutical Research.
[137] Samir Mitragotri,et al. Shape Induced Inhibition of Phagocytosis of Polymer Particles , 2008, Pharmaceutical Research.
[138] Michael Sixt,et al. Lymph node chemokines promote sustained T lymphocyte motility without triggering stable integrin adhesiveness in the absence of shear forces , 2007, Nature Immunology.
[139] Sai T Reddy,et al. Exploiting lymphatic transport and complement activation in nanoparticle vaccines , 2007, Nature Biotechnology.
[140] Samir Mitragotri,et al. Particle shape: a new design parameter for micro- and nanoscale drug delivery carriers. , 2007, Journal of controlled release : official journal of the Controlled Release Society.
[141] M. Jenkins,et al. The humoral immune response is initiated in lymph nodes by B cells that acquire soluble antigen directly in the follicles. , 2007, Immunity.
[142] Jason K. Pontrello,et al. Activating B cell signaling with defined multivalent ligands. , 2007, ACS chemical biology.
[143] Noriaki Okamoto,et al. Artificial lymph nodes induce potent secondary immune responses in naive and immunodeficient mice. , 2007, The Journal of clinical investigation.
[144] T. Fahmy,et al. A nanoscopic multivalent antigen-presenting carrier for sensitive detection and drug delivery to T cells. , 2007, Nanomedicine : nanotechnology, biology, and medicine.
[145] W. Roos,et al. Cell-assisted assembly of colloidal crystallites. , 2007, Soft matter.
[146] Krishnendu Roy,et al. Biomaterial-based notch signaling for the differentiation of hematopoietic stem cells into T cells. , 2006, Journal of biomedical materials research. Part A.
[147] Sai T Reddy,et al. Targeting dendritic cells with biomaterials: developing the next generation of vaccines. , 2006, Trends in immunology.
[148] S. Rosenberg,et al. Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes , 2006, Science.
[149] Uwe Marx,et al. A human lymph node in vitro--challenges and progress. , 2006, Artificial organs.
[150] A. Zahr,et al. Macrophage uptake of core-shell nanoparticles surface modified with poly(ethylene glycol). , 2006, Langmuir : the ACS journal of surfaces and colloids.
[151] Jean-Pierre Benoit,et al. Parameters influencing the stealthiness of colloidal drug delivery systems. , 2006, Biomaterials.
[152] Sai T Reddy,et al. In vivo targeting of dendritic cells in lymph nodes with poly(propylene sulfide) nanoparticles. , 2006, Journal of controlled release : official journal of the Controlled Release Society.
[153] S. Liao,et al. Lymphoid organ development: from ontogeny to neogenesis , 2006, Nature Immunology.
[154] P. Kozlowski,et al. Mucosal vaccines: the promise and the challenge , 2006, Nature Reviews Immunology.
[155] Nicholas A Peppas,et al. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. , 2006, International journal of pharmaceutics.
[156] K. Landfester,et al. Preparation of Fluorescent Carboxyl and Amino Functionalized Polystyrene Particles by Miniemulsion Polymerization as Markers for Cells , 2005 .
[157] C. Coban,et al. Manifold Mechanisms of Toll-Like Receptor-Ligand Recognition , 2005, Journal of Clinical Immunology.
[158] J. Babensee,et al. Differential levels of dendritic cell maturation on different biomaterials used in combination products. , 2005, Journal of biomedical materials research. Part A.
[159] Sven Frokjaer,et al. Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model. , 2005, International journal of pharmaceutics.
[160] J. Strominger,et al. Differential induction of IgE-mediated anaphylaxis after soluble vs. cell-bound tolerogenic peptide therapy of autoimmune encephalomyelitis. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[161] J. Babensee,et al. The effect of the physical form of poly(lactic-co-glycolic acid) carriers on the humoral immune response to co-delivered antigen. , 2005, Biomaterials.
[162] Harry E Rubash,et al. Gene expression clustering using self-organizing maps: analysis of the macrophage response to particulate biomaterials. , 2005, Biomaterials.
[163] Jan Holmgren,et al. Mucosal immunity and vaccines , 2005, Nature Medicine.
[164] Bengt Rippe,et al. Ficoll and dextran vs. globular proteins as probes for testing glomerular permselectivity: effects of molecular size, shape, charge, and deformability. , 2005, American journal of physiology. Renal physiology.
[165] Daniel Coombs,et al. T cell receptor binding kinetics required for T cell activation depend on the density of cognate ligand on the antigen-presenting cell. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[166] S. Metcalfe,et al. Leukemia Inhibitory Factor Is Linked to Regulatory Transplantation Tolerance , 2005, Transplantation.
[167] Anna Bershteyn,et al. Bioactive Hydrogels with an Ordered Cellular Structure Combine Interconnected Macroporosity and Robust Mechanical Properties , 2005 .
[168] M. Ferrari,et al. A Theoretical Model for the Margination of Particles within Blood Vessels , 2005, Annals of Biomedical Engineering.
[169] Jeffrey A Hubbell,et al. Oxidation-sensitive polymeric nanoparticles. , 2005, Langmuir : the ACS journal of surfaces and colloids.
[170] S. Shaw,et al. Conduit for privileged communications in the lymph node. , 2005, Immunity.
[171] J. Cyster,et al. Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs. , 2005, Annual review of immunology.
[172] Takeshi Watanabe,et al. Generation of a synthetic lymphoid tissue–like organoid in mice , 2004, Nature Biotechnology.
[173] W. Hancock,et al. Approach to the comprehensive analysis of glycoproteins isolated from human serum using a multi-lectin affinity column. , 2004, Journal of chromatography. A.
[174] Jie Li,et al. Size-Dependent Immunogenicity: Therapeutic and Protective Properties of Nano-Vaccines against Tumors1 , 2004, The Journal of Immunology.
[175] S. Rosenberg,et al. Cancer immunotherapy: moving beyond current vaccines , 2004, Nature Medicine.
[176] J. Babensee,et al. Humoral immune responses to model antigen co-delivered with biomaterials used in tissue engineering. , 2004, Biomaterials.
[177] R. Mebius. Organogenesis of lymphoid tissues , 2003, Nature reviews. Immunology.
[178] M. Alonso,et al. Biodegradable micro- and nanoparticles as long-term delivery vehicles for interferon-alpha. , 2003, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[179] Allison L. Sieving,et al. Morphological characteristics of total joint arthroplasty-derived ultra-high molecular weight polyethylene (UHMWPE) wear debris that provoke inflammation in a murine model of inflammation. , 2003, Journal of biomedical materials research. Part A.
[180] M. Raffeld,et al. Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes , 2002, Science.
[181] C. Geisler,et al. A Response Calculus for Immobilized T Cell Receptor Ligands* , 2001, The Journal of Biological Chemistry.
[182] H. Merkle,et al. Evaluation of particle uptake in human blood monocyte-derived cells in vitro. Does phagocytosis activity of dendritic cells measure up with macrophages? , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[183] S M Moghimi,et al. Long-circulating and target-specific nanoparticles: theory to practice. , 2001, Pharmacological reviews.
[184] Jian Ding,et al. PEGylated polycyanoacrylate nanoparticles as tumor necrosis factor-α carriers , 2001 .
[185] Younan Xia,et al. Self‐Assembly of Monodispersed Spherical Colloids into Complex Aggregates with Well‐Defined Sizes, Shapes, and Structures , 2001 .
[186] J. Frank,et al. Encephalitogenic potential of the myelin basic protein peptide (amino acids 83–99) in multiple sclerosis: Results of a phase II clinical trial with an altered peptide ligand , 2000, Nature Medicine.
[187] T. Meyer,et al. Efficient generation of human T cells from a tissue-engineered thymic organoid , 2000, Nature Biotechnology.
[188] A. Mikos,et al. Controlled release of transforming growth factor β1 from biodegradable polymer microparticles , 2000 .
[189] D. Fischer,et al. Surface-modified biodegradable albumin nano- and microspheres. II: effect of surface charges on in vitro phagocytosis and biodistribution in rats. , 1998, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[190] F. Yuan,et al. Transvascular drug delivery in solid tumors. , 1998, Seminars in radiation oncology.
[191] Smadar Cohen,et al. Characterization of PLGA microspheres for the controlled delivery of IL-1α for tumor immunotherapy , 1997 .
[192] Gert Storm,et al. Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system , 1995 .
[193] R. Müller,et al. The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres. , 1995, Advanced drug delivery reviews.
[194] V. Torchilin,et al. Biodegradable long-circulating polymeric nanospheres. , 1994, Science.
[195] E. Jaffee,et al. Controlled release, biodegradable cytokine depots: a new approach in cancer vaccine design. , 1993, Cancer research.
[196] R. K. Rana,et al. Controlled Release of Interleukin-2 from Biodegradable Microspheres , 1990, Bio/Technology.
[197] J. Thompson,et al. Recombinant interleukin 2 toxicity, pharmacokinetics, and immunomodulatory effects in a phase I trial. , 1987, Cancer research.
[198] Clive G. Wilson,et al. Blood clearance and organ deposition of intravenously administered colloidal particles. The effects of particle size, nature and shape , 1982 .
[199] R L Juliano,et al. The effect of particle size and charge on the clearance rates of liposomes and liposome encapsulated drugs. , 1975, Biochemical and biophysical research communications.
[200] H. Baumgartner,et al. The role of blood flow in platelet adhesion, fibrin deposition, and formation of mural thrombi. , 1973, Microvascular research.